β-Amyrin Ameliorates Alzheimer's Disease-Like Aberrant Synaptic Plasticity in the Mouse Hippocampus.

Alzheimer's disease Amyloid β Synaptic plasticity β-amyrin

Journal

Biomolecules & therapeutics
ISSN: 1976-9148
Titre abrégé: Biomol Ther (Seoul)
Pays: Korea (South)
ID NLM: 101472832

Informations de publication

Date de publication:
01 Jan 2020
Historique:
received: 08 02 2019
revised: 13 06 2019
accepted: 17 06 2019
pubmed: 31 7 2019
medline: 31 7 2019
entrez: 31 7 2019
Statut: ppublish

Résumé

Alzheimer's disease (AD) is a progressive and most frequently diagnosed neurodegenerative disorder. However, there is still no drug preventing the progress of this disorder. β-Amyrin, an ingredient of the surface wax of tomato fruit and dandelion coffee, is previously reported to ameliorate memory impairment induced by cholinergic dysfunction. Therefore, we tested whether β-amyrin can prevent AD-like pathology. β-Amyrin blocked amyloid β (Aβ)-induced long-term potentiation (LTP) impairment in the hippocampal slices. Moreover, β-amyrin improved Aβ-induced suppression of phosphatidylinositol-3-kinase (PI3K)/Akt signaling. LY294002, a PI3K inhibitor, blocked the effect of β-amyrin on Aβ-induced LTP impairment. In

Identifiants

pubmed: 31357749
pii: biomolther.2019.024
doi: 10.4062/biomolther.2019.024
pmc: PMC6939697
doi:

Types de publication

Journal Article

Langues

eng

Pagination

74-82

Références

Biol Pharm Bull. 2014;37(7):1207-13
pubmed: 24989012
Lipids Health Dis. 2012 Aug 06;11:98
pubmed: 22867128
J Anat. 2011 Jul;219(1):78-89
pubmed: 21323664
Phytochem Rev. 2012 Jun;11(2-3):263-284
pubmed: 23519009
Pharmacol Ther. 2015 Apr;148:114-31
pubmed: 25435019
Lancet Neurol. 2007 Aug;6(8):734-46
pubmed: 17616482
Br J Pharmacol. 2015 May;172(9):2354-68
pubmed: 25560396
J Basic Clin Pharm. 2016 Mar;7(2):27-31
pubmed: 27057123
FASEB J. 2009 Mar;23(3):739-50
pubmed: 19001528
J Biol Chem. 2015 Nov 20;290(47):28540-58
pubmed: 26420483
Sci Rep. 2015 Jan 21;5:7912
pubmed: 25604482
Brain Pathol. 2016 Jan;26(1):62-74
pubmed: 25763997
J Neurosci Res. 2009 Aug 1;87(10):2297-307
pubmed: 19301428
Psychopharmacology (Berl). 2019 Apr;236(4):1281-1292
pubmed: 30515523
Pharm Biol. 2014 Nov;52(11):1478-86
pubmed: 25026352
Mol Neurodegener. 2017 Mar 21;12(1):27
pubmed: 28327181
Oncotarget. 2017 Apr 25;8(17):27676-27692
pubmed: 28430602
PLoS One. 2008 Aug 13;3(8):e2935
pubmed: 18698410
Science. 2002 Jul 19;297(5580):353-6
pubmed: 12130773
J Neuroinflammation. 2012 Apr 02;9:62
pubmed: 22472085
Nature. 2002 Apr 4;416(6880):535-9
pubmed: 11932745
Proc Natl Acad Sci U S A. 2014 Jul 8;111(27):9959-64
pubmed: 24958880
Alzheimers Res Ther. 2014 Jun 20;6(3):35
pubmed: 25031641
Neurobiol Aging. 2015 Jan;36(1):123-33
pubmed: 25104560
Behav Brain Res. 2015 Sep 15;291:232-236
pubmed: 26026786
Nature. 2014 Jul 17;511(7509):348-52
pubmed: 24896183
Phytomedicine. 2012 Jun 15;19(8-9):682-5
pubmed: 22541636
Front Mol Neurosci. 2017 Jul 04;10:214
pubmed: 28725178
Neuron. 1991 Apr;6(4):487-98
pubmed: 1673054
Neuropharmacology. 2018 Jan;128:282-292
pubmed: 29079294
Biochim Biophys Acta. 2013 Dec;1832(12):1913-21
pubmed: 23816568
Acta Neuropathol. 2015 Feb;129(2):183-206
pubmed: 25604547
J Psychosom Res. 2006 Sep;61(3):311-6
pubmed: 16938507
Nat Neurosci. 2011 May;14(5):545-7
pubmed: 21441921
Mol Neurodegener. 2011 Dec 22;6:85
pubmed: 22192775
Cell Death Dis. 2015 Jun 18;6:e1791
pubmed: 26086964
Eur J Pharmacol. 2014 Jul 5;734:77-82
pubmed: 24726843
J Vis Exp. 2016 Mar 16;(109):null
pubmed: 27023127
J Neurochem. 2002 Dec;83(6):1509-24
pubmed: 12472904
Biochem Biophys Res Commun. 2015 Nov 27;467(4):676-82
pubmed: 26498523
PLoS One. 2014 Jan 23;9(1):e86237
pubmed: 24465980
Br J Pharmacol. 2012 Dec;167(8):1596-608
pubmed: 22646533
Hum Exp Toxicol. 2017 Feb;36(2):113-122
pubmed: 27009110
Curr Alzheimer Res. 2011 Nov;8(7):707-17
pubmed: 21453244
Nature. 2017 Sep 21;549(7672):384-388
pubmed: 28902836
Neurobiol Learn Mem. 2015 May;121:20-9
pubmed: 25838119
Pain. 2011 Aug;152(8):1872-87
pubmed: 21620566
Neurosci Biobehav Rev. 2016 Jun;65:326-40
pubmed: 27044452
Inflammopharmacology. 2014 Dec;22(6):373-85
pubmed: 25300965

Auteurs

Hye Jin Park (HJ)

Department of Medicinal Biotechnology, College of Health Sciences, Dong-A University, Busan 49315, Republic of Korea.

Huiyoung Kwon (H)

Department of Medicinal Biotechnology, College of Health Sciences, Dong-A University, Busan 49315, Republic of Korea.

Ji Hye Lee (JH)

Division of Endocrinology, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea.

Eunbi Cho (E)

Department of Medicinal Biotechnology, College of Health Sciences, Dong-A University, Busan 49315, Republic of Korea.

Young Choon Lee (YC)

Department of Medicinal Biotechnology, College of Health Sciences, Dong-A University, Busan 49315, Republic of Korea.
Institute of Convergence Bio-Health, Dong-A University, Busan 49315, Republic of Korea.

Minho Moon (M)

Department of Biochemistry, College of Medicine, Konyang University, Daejeon 35365, Republic of Korea.

Mira Jun (M)

Institute of Convergence Bio-Health, Dong-A University, Busan 49315, Republic of Korea.
Department of Food Science and Nutrition, College of Health Sciences, Dong-A University, Busan 49315, Republic of Korea.

Dong Hyun Kim (DH)

Department of Medicinal Biotechnology, College of Health Sciences, Dong-A University, Busan 49315, Republic of Korea.
Institute of Convergence Bio-Health, Dong-A University, Busan 49315, Republic of Korea.

Ji Wook Jung (JW)

Department of Herbal Medicinal Pharmacology, College of Herbal Bio-industry, Daegu Haany University, Kyungsan 38610, Republic of Korea.

Classifications MeSH